Therefore, the results of this study further support the previously observed neuroprotective role of MR and suggest that MR agonists may represent a possible therapeutic strategy for reducing hippocampal cell loss, improving neurogenesis and for approaching neurodegenerative diseases, such as AD. This evidence concerns the gene NR3C2 and Alzheimer disease.